Related Experiment Video
Updated: Dec 13, 2025

A High-throughput Shigella-specific Bactericidal Assay
Published on: February 27, 2019
Early Insights From Clinical Trials of Typhoid Conjugate Vaccine
Kathleen M Neuzil1, Buddha Basnyat2, John D Clemens3
1University of Maryland School of Medicine, Baltimore, Maryland, USA.
Abstract:
Clinical trials of typhoid conjugate vaccine (TCV) are ongoing in 4 countries. Early data confirm safety, tolerability, and immunogenicity of typhoid conjugate vaccine, and early efficacy results are promising. These data support World Health Organization recommendations and planned country introductions. Forthcoming trial data will continue to inform programmatic use of typhoid conjugate vaccine.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Vaccinations
Clinical Trials: Overview